Ohio Clinical Trials

Columbus, Ohio 43212

5 studies enrolling now · 12 studies all time

What they study most

Alcohol Use Disorder, Cirrhosis, Liver, Healthy Participants, Human Abuse Potential, Hypercholesterolemia, Liver Fat, Liver Fibrosis, Liver Inflammation, Liver Steatoses, Metabolic Associated Fatty Liver Disease, Metabolic Associated Steatotic Liver Disease, NASH

Studies at this site

• A Study of Brenipatide in Participants With Opioid Use Disorder — Recruiting now
• Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D — Recruiting now
• REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants — Recruiting now
• A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia — Recruiting now
• Evaluation of Non-Invasive Tests for Metabolic Liver Disease — Recruiting now
• Study of Sunobinop on Craving in Alcohol Use Disorder — Completed
• Pharmacokinetic (PK) Evaluation of Nalmefene Formulations — Completed
• Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder — Completed
• A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight — Completed
• A Phase 1a Study of PMN310 In Healthy Volunteers — Completed
• Pharmacodynamic Evaluation of Intramuscular Nalmefene Autoinjector 1.5 mg Compared to Intranasal Narcan 4 mg — Completed
• Assessment of Abuse Potential of Cebranopadol in Humans — Completed